Written by Julia Rostova
The cleanest way to read Darden this week is not as a turnaround and not quite as a rerating story. It is a high-quality operator using a strong quarter, durable cash generation, and a fresh $1.5 billion repurchase authorization to remind the market that it still deserves a premium to much of casual dining. That message is fair. What is less clear is whether investors should pay materially more for that quality from here.
The company’s latest results were undeniably solid. Fourth-quarter sales rose 13.7% to $3.72 billion, helped by an extra operating week, 4.6% blended same-restaurant sales growth, and 43 net new restaurants. Olive Garden posted 2.4% same-restaurant sales growth, while LongHorn Steakhouse delivered a much stronger 9.5%. Adjusted diluted EPS from continuing operations reached $3.66, up 22.8%, and Darden repurchased $138 million of stock during the quarter. Management also raised the quarterly dividend to $1.62 per share and authorized a new $1.5 billion buyback program with no expiration. For fiscal 2027, the company guided to $13.60 billion to $13.75 billion in sales, same-restaurant sales growth of 2.5% to 3.5%, and 75 to 80 new restaurant openings.
That is the profile of a company operating from a position of strength. Darden is not leaning on financial engineering to hide weak traffic or a collapsing concept mix. Its portfolio remains broad, with brands that include Olive Garden, LongHorn, Yard House, Ruth’s Chris, Chuy’s, Cheddar’s, The Capital Grille, Seasons 52, and Eddie V’s, according to the company profile hosted by Nasdaq. The breadth matters. In a consumer environment where value sensitivity and selective spending still coexist, diversification across concepts gives Darden more room to absorb weakness in one brand than a narrower peer can.
The market already recognizes that quality. Nasdaq summary data shows Darden closed at $212.76 with a one-year consensus target of $230.00 and a market value near $24.48 billion. On Finviz, the stock screens at 20.58 times trailing earnings, 17.22 times forward earnings, 2.09 times PEG, and 13.98 times EV/EBITDA, with an analyst target price around $231.46. None of those figures suggests a distressed or neglected stock. Investors are already paying for consistency.
That is where the buyback needs to be interpreted carefully. Buybacks are most powerful when they either exploit a clear valuation gap or reinforce a very long runway for compounding. Darden’s new authorization certainly reinforces management confidence, and CFO Raj Vennam explicitly tied capital returns to durable cash generation and 9% annualized adjusted EBITDA growth since 2019. But a vote of confidence is not the same thing as a fresh undervaluation signal. At current multiples, the repurchase program looks more like disciplined capital allocation than a catalyst that should automatically push the stock into a meaningfully higher valuation band.
The peer set helps frame that point.
| Stock | Company | Verdict | Price Target | Key framing |
| DRI | Darden Restaurants | HOLD | $228 | High-quality portfolio and credible cash returns, but valuation already reflects much of the quality story. |
| TXRH | Texas Roadhouse | HOLD | $198 | Best-in-class traffic momentum, but premium multiple leaves less room for error. |
| CAKE | Cheesecake Factory | HOLD | $66 | Reasonable execution and improving earnings leverage, though brand and traffic durability are less premium than Darden’s. |
| EAT | Brinker International | BUY | $186 | Cheapest valuation in the set with decent growth support, though operational cyclicality remains higher. |
Take Texas Roadhouse first. It is the premium growth comparator. Nasdaq summary data shows a one-year target of $194.13 and market cap near $12.92 billion, while Finviz shows 31.41 times trailing earnings, 25.63 times forward earnings, 1.75 PEG, and 18.91 EV/EBITDA. Texas Roadhouse has earned a premium because traffic and execution have been unusually strong, but at those levels the multiple is already doing most of the storytelling. Darden looks cheaper than Texas Roadhouse, yes, but not so cheap that the spread alone forces a buy call.
Cheesecake sits closer to the middle. Nasdaq gives it a one-year target of $67.76 and a market cap around $3.94 billion. Finviz shows 23.55 times trailing earnings, 18.02 times forward earnings, 1.90 PEG, and 15.95 EV/EBITDA. That makes Cheesecake not obviously inexpensive, but still priced as a more moderate-quality operator than Darden. If Darden were trading at a material discount to this level of quality-adjusted valuation, the bull case would be easier. It is not.
The most interesting valuation contrast is Brinker. Nasdaq shows a one-year target of $177.93 and market cap near $7.33 billion, while Finviz screens it at 16.79 times trailing earnings, 13.72 times forward earnings, 0.87 PEG, and 10.87 EV/EBITDA. Brinker is clearly the cheaper name, and that lower multiple reflects a more operationally levered, less defensive setup. Still, if an investor wants value inside the restaurant group, Brinker makes the cleaner argument today than Darden does.
So what is the actual Darden bull case? It starts with the idea that quality deserves a premium in a slower-growth consumer tape. Olive Garden remains a scale asset. LongHorn is still delivering excellent momentum. The portfolio mix reduces single-brand risk. Cash generation is real. The dividend is growing. The buyback is large and open-ended. If management executes to the top end of its 2027 outlook and keeps same-restaurant sales firm while opening stores at the guided pace, the stock can continue compounding even without a dramatic multiple expansion.
The bear case is simpler. Darden may be moving from high-quality compounder to high-quality fully valued compounder. That is an important distinction. Investors paying more than 20 times trailing earnings and almost 14 times EBITDA for a mature restaurant platform should demand continued execution with very few stumbles. Any softening in traffic, margin pressure from labor or commodities, or a weakening of Olive Garden’s value positioning would make the multiple feel less forgiving.
My view is that Darden remains a fundamentally attractive company but a merely adequate stock at current levels. The new buyback matters because it confirms management confidence and reinforces shareholder returns. It does not, by itself, create a new thesis. The thesis still depends on sustained operating excellence, healthy consumer demand, and the company’s ability to keep its brand portfolio productive without overpaying for growth.
That is enough to stay constructive, but not enough to chase. In this group, Darden deserves respect. It just does not yet deserve a fresh premium repricing.
